Replies to post #766418 on NorthWest Biotherapeutics Inc (NWBO)

[norisknorewards]

10q is coming next week

[KevGee59]

They are more than free to update on Direct restart, Flaskworks, combo trials, booster agents, etc.

100% Spot On!

[bas2020]

Oh, really? And run the risk of another "promotion" complaint by the cabal. SMH No thanks!

They are more than free to update on Direct restart, Flaskworks, combo trials, booster agents, etc.

Cabal soldiers are hoping for something, anything, they can complain to the authorities about with false accusations.

[dstock07734]

How do you feel about the efficacy from this tumor-agnostic trial on the treatment of 11 types of tough pediatric rare cancers with DCVax-L? Is that amazing?

Note this is DCVax-L alone case without poly-iclc being included. You would agree those who short the company don't have any chance to win, would you not?

Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients
https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.35062

We analyzed data from all consecutive patients who received personalized DC vaccine between 2016 and 2022. Inclusion criteria were children and young adults, aged 0–20 years at diagnosis with relapsed/refractory and/or metastasizing high-risk solid tumors diagnosed in 2005–2021, who received at least two doses of DC vaccine as part of multimodal individualized combination treatment and who signed (or whose legal guardians signed) an informed consent.

We observed repeated recurrences or progressions, however, with favorable overall survival. Three- and five-year overall survival was 80.8% and 60.2%, and 60.4% and 30.2%, respectively, when calculated from the first progression. This is a notable outcome for such a high-risk cohort in comparison to historical data,21–26 where 3-year survival ranged from 15% to 30% and 5-year survival was generally <15% from recurrence

[Doc logic]

FeMike,

Hey we are all frustrated with how long this is taking but we both were looking at manufacturing being key more than two years ago. You basically said you hoped we would not be stuck with that burden but look at where we are at. Could it really have been anything else? By the way, insiders and friends may be able to work the best deals with the least risk but the low price is there for all investors to take advantage of. You were spacing your buys out by about a $.05 as I recall so you should have been able to get some at $.20 and I don’t think that opportunity makes us insiders or close friends. Granted we don’t get attached warrants but when validation finally comes anyone buying down at this level is not going to be complaining about anything other than wishing they had bought more. This is especially true if they were buying to hold and support NWBO efforts to get this platform to patients while also keeping shares out of the hands of those desiring to derail that effort; ). Best wishes.